Citadel Advisors’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,600
Closed -$10.4K 15386
2023
Q2
$10.4K Sell
10,600
-5,200
-33% -$5.35K ﹤0.01% 13208
2023
Q1
$18K Sell
15,800
-65,500
-81% -$95.1K ﹤0.01% 13139
2022
Q4
$65.1K Sell
81,300
-8,100
-9% -$10.3K ﹤0.01% 11802
2022
Q3
$140K Buy
89,400
+58,800
+192% +$121K ﹤0.01% 10789
2022
Q2
$55K Sell
30,600
-20,000
-40% -$41.8K ﹤0.01% 11878
2022
Q1
$160K Buy
50,600
+9,500
+23% +$23K ﹤0.01% 11784
2021
Q4
$125K Sell
41,100
-33,800
-45% -$158K ﹤0.01% 12483
2021
Q3
$467K Buy
74,900
+44,900
+150% +$299K ﹤0.01% 10042
2021
Q2
$256K Buy
30,000
+15,300
+104% +$157K ﹤0.01% 11652
2021
Q1
$225K Buy
+14,700
New +$239K ﹤0.01% 11478

Other funds holding BCEL

Citadel Advisors's BCEL Position: Q3 2023 in Review

Citadel Advisors sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q3 2023, closing a stake of 440 shares — an estimated $431 sold.

Citadel Advisors first reported a position in BCEL in Q2 2019 and held it in 16 quarters. The position peaked at $9.86M in Q4 2020. 45 funds tracked by Wall St. Rank hold BCEL as of Q3 2023.

  • Citadel Advisors reported no remaining Atreca, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 440 Atreca, Inc. Class A Common Stock shares in Q3 2023, an estimated $431.
  • Citadel Advisors first reported a position in Atreca, Inc. Class A Common Stock in Q2 2019 and held it in 16 quarters.
  • Citadel Advisors's Atreca, Inc. Class A Common Stock position peaked at $9.86M in Q4 2020.
  • 45 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.